The DCB looks good in select cases, but given its high price tag, exactly when to use it is still up for discussion, say ...

Boston Scientific (NYSE:BSX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a ...

StockNews.com upgraded shares of Boston Scientific (NYSE:BSX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday. A number of other equities analysts ...

In a wide manufacturing room with white walls and low ceilings, Boston Scientific employees combine components into finished ...

The intracranial stents market is experiencing rapid growth, fueled by the rising incidence of strokes, aneurysms, and ...

We recently published a list of Israel Englander’s Stock Portfolio: Top 10 Stocks to Invest in. In this article, we are going ...

Boston Scientific Corporation ( NYSE: BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - ...

Boston Scientific Corporation develops ... such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters ...

The increasing prevalence of neurological disorders, such as cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs), is the key factor fueling the demand for interventional ...